ID
34533
Description
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01443364
Link
https://clinicaltrials.gov/show/NCT01443364
Keywords
Versions (1)
- 1/19/19 1/19/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 19, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT01443364
Eligibility Rheumatoid Arthritis NCT01443364
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Arthritis
Data type
boolean
Alias
- UMLS CUI [1]
- C0003864
Description
Prosthetic joint infection | Communicable Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0410808
- UMLS CUI [2]
- C0009450
Description
Tuberculosis | High risk of Tuberculosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0041296
- UMLS CUI [2,1]
- C0332167
- UMLS CUI [2,2]
- C0041296
Similar models
Eligibility Rheumatoid Arthritis NCT01443364
- StudyEvent: Eligibility
C0003873 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C1320283 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0005515 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2])
C0332167 (UMLS CUI [2,1])
C0041296 (UMLS CUI [2,2])